← Leaderboards
John B Sunwoo
Stanford University
$14,810,025
Attributed
$20,782,502
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,782,502 · 10
By mechanism
U01$6,032,060 · 2
R01$5,748,807 · 3
R35$5,721,403 · 1
U54$1,837,370 · 1
K08$607,986 · 1
R56$435,737 · 1
Top collaborators
- Olivier Gevaert4 shared
- Calvin J Kuo4 shared
- Joshua E Elias3 shared
- David K Lam3 shared
- Rebecca Moazzez3 shared
- Ruth M O'Hara3 shared
- Guillem Pratx3 shared
- Yunzhi Yang3 shared
Most similar at Stanford University
Same institution · by research overlap
- Maarten G Lansberg$12,308,726
- Scott Dexter Boyd$18,651,021
- Guillem Pratx$5,556,207
- Yunzhi Yang$11,928,757
- Calvin J Kuo$48,363,495
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsCellsResponseNeoplastic CellImmuneImmune SystemInsightTissuesMediatingOperative Surgical ProceduresIn VitroFutureCell PhysiologyPrimary NeoplasmAffectImmune ResponseNatural Killer CellsSamplingHead And Neck Squamous Cell CarcinomaReportingIn VivoInvestigationMutation
Grant awards (40)
Reprogramming the Tumor-Immune Interface in Oral Cancer$962,342
R35 · FY2025 · DE · contact PI
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$758,372
U01 · FY2025 · DE
Preclinical microphysiological tumor models for nuclear medicine$514,734
R01 · FY2025 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer$959,255
R35 · FY2024 · DE · contact PI
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$741,589
U01 · FY2024 · DE
Preclinical microphysiological tumor models for nuclear medicine$513,249
R01 · FY2024 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer$994,309
R35 · FY2023 · DE · contact PI
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers$764,646
U01 · FY2023 · DE
Preclinical microphysiological tumor models for nuclear medicine$529,906
R01 · FY2023 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer$999,772
R35 · FY2022 · DE · contact PI
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects$467,405
R01 · FY2022 · DE · contact PI
Reprogramming the Tumor-Immune Interface in Oral Cancer$1,024,729
R35 · FY2021 · DE · contact PI
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects$470,649
R01 · FY2021 · DE · contact PI
Reprogramming the Tumor-Immune Interface in Oral Cancer$780,996
R35 · FY2020 · DE · contact PI
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects$492,627
R01 · FY2020 · DE · contact PI
Core 1: Biospecimen and Data Management Core$315,569
U54 · FY2020 · CA · contact PI
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects$503,244
R01 · FY2019 · DE · contact PI
Core 1: Biospecimen and Data Management Core$401,189
U54 · FY2019 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$924,971
U01 · FY2018 · DE · contact PI
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects$509,534
R01 · FY2018 · DE
Core 1: Biospecimen and Data Management Core$382,650
U54 · FY2018 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$924,971
U01 · FY2017 · DE · contact PI
Core 1: Biospecimen and Data Management Core$369,028
U54 · FY2017 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$947,802
U01 · FY2016 · DE · contact PI
Core 1: Biospecimen and Data Management Core$368,934
U54 · FY2016 · CA · contact PI
Enhancement of Natural Killer Cell Effector Functions$355,898
R01 · FY2016 · CA · contact PI
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer$969,709
U01 · FY2015 · DE · contact PI
Enhancement of Natural Killer Cell Effector Functions$355,898
R01 · FY2015 · CA · contact PI
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses$180,843
R21 · FY2015 · CA · contact PI
Characterization and Targeting of CD271 in Oral Cancer-Initiating Cells$435,737
R56 · FY2014 · DE · contact PI
Enhancement of Natural Killer Cell Effector Functions$345,221
R01 · FY2014 · CA · contact PI
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses$218,296
R21 · FY2014 · CA · contact PI
Enhancement of Natural Killer Cell Effector Functions$334,544
R01 · FY2013 · CA · contact PI
Enhancement of Natural Killer Cell Effector Functions$355,898
R01 · FY2012 · CA · contact PI
Mechanisms of Immune Evasion by Head and Neck Cancer$121,597
K08 · FY2008 · DE · contact PI
Mechanisms of Immune Evasion by Head and Neck Cancer$1
K08 · FY2008 · DE · contact PI
Mechanisms of Immune Evasion by Head and Neck Cancer$121,597
K08 · FY2007 · DE · contact PI
Mechanisms of Immune Evasion by Head and Neck Cancer$121,597
K08 · FY2006 · DE · contact PI
Mechanisms of Immune Evasion by Head and Neck Cancer$121,597
K08 · FY2005 · DE
Mechanisms of Immune Evasion by Head and Neck Cancer$121,597
K08 · FY2004 · DE